Shanghai, China

Wei Yu

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Wei Yu: Innovator in Pharmaceutical Manufacturing

Introduction

Wei Yu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical manufacturing, holding a total of 2 patents. His work focuses on innovative methods that enhance the production of important pharmaceutical compounds.

Latest Patents

Wei Yu's latest patents include a method for the manufacture of 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine and polymorphic forms thereof. This specification generally relates to an improved method for the manufacture of this compound, or pharmaceutically acceptable salts thereof, along with intermediates useful in the manufacture of such compounds and salts. Another significant patent is the low-temperature continuous-flow preparation method of bedaquiline. This method involves a series of continuous flow reactions that ultimately produce bedaquiline, showcasing an innovative approach to pharmaceutical synthesis.

Career Highlights

Wei Yu has worked with prestigious institutions such as Shanghai Jiao Tong University and Sph No. 1 Biochemical & Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative techniques in pharmaceutical manufacturing.

Collaborations

Wei has collaborated with notable professionals in his field, including Andrew Turner and Wanbin Zhang. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Wei Yu is a prominent inventor whose work in pharmaceutical manufacturing has led to significant advancements in the field. His innovative methods and collaborations highlight his commitment to improving drug production processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…